Paper37259352
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances.
Tammaro C and 5 others. Pharmaceuticals (Basel), 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances. Papers, record 37259352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37259352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32045235 | α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment. | J Med Chem | 2020 | https://conductscience.org/library/papers/32045235 | PubMed |
| 2 | 29626210 | The life cycle of non-polio enteroviruses and how to target it. | Nat Rev Microbiol | 2018 | https://conductscience.org/library/papers/29626210 | PubMed |
| 3 | 31883926 | N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication and inflammatory response. | Antiviral Res | 2020 | https://conductscience.org/library/papers/31883926 | PubMed |
| 4 | 6113314 | The activity of enviroxime against rhinovirus infection in man. | Lancet | 1981 | https://conductscience.org/library/papers/6113314 | PubMed |
| 5 | 28218309 | Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A. | Sci Rep | 2017 | https://conductscience.org/library/papers/28218309 | PubMed |
| 6 | 25891300 | Phosphatidylinositol 4-kinase III beta is the target of oxoglaucine and pachypodol (Ro 09-0179) for their anti-poliovirus activities, and is located at upstream of the target step of brefeldin A. | Microbiol Immunol | 2015 | https://conductscience.org/library/papers/25891300 | PubMed |
| 7 | 25229269 | First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis. | Pediatr Infect Dis J | 2015 | https://conductscience.org/library/papers/25229269 | PubMed |
| 8 | 35847514 | Enterovirus A71 antivirals: Past, present, and future. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35847514 | PubMed |
| 9 | 14638501 | Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/14638501 | PubMed |
| 10 | 35891332 | The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication. | Viruses | 2022 | https://conductscience.org/library/papers/35891332 | PubMed |
| 11 | 25752737 | Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP. | Antiviral Res | 2015 | https://conductscience.org/library/papers/25752737 | PubMed |
| 12 | 26071135 | Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds. | Antivir Chem Chemother | 2015 | https://conductscience.org/library/papers/26071135 | PubMed |
| 13 | 28088354 | Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307. | Antiviral Res | 2017 | https://conductscience.org/library/papers/28088354 | PubMed |
| 14 | 26266417 | Replication and Inhibitors of Enteroviruses and Parechoviruses. | Viruses | 2015 | https://conductscience.org/library/papers/26266417 | PubMed |
| 15 | 31909201 | Glutathione facilitates enterovirus assembly by binding at a druggable pocket. | Commun Biol | 2020 | https://conductscience.org/library/papers/31909201 | PubMed |
| 16 | 23365445 | Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. | J Virol | 2013 | https://conductscience.org/library/papers/23365445 | PubMed |
| 17 | 35603180 | Host Restrictive Factors Are the Emerging Storm Troopers Against Enterovirus: A Mini-Review. | Front Immunol | 2022 | https://conductscience.org/library/papers/35603180 | PubMed |
| 18 | 19237651 | Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19237651 | PubMed |
| 19 | 31271764 | Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds. | Antiviral Res | 2019 | https://conductscience.org/library/papers/31271764 | PubMed |
| 20 | 24393668 | Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases. | Antiviral Res | 2014 | https://conductscience.org/library/papers/24393668 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41516027 | Targeting Host Dependency Factors: A Paradigm Shift in Antiviral Strategy Against RNA Viruses. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516027 | PubMed |
| 41471867 | Unraveling the Potential Antiviral Activity of Isoxazoline-Carbocyclic Monophosphate Nucleotides Against Echovirus 11. | Microorganisms | 2025 | https://conductscience.org/library/papers/41471867 | PubMed |
| 41435219 | Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab: Insights From a Multicenter Case Series. | Neurol Neuroimmunol Neuroinflamm | 2026 | https://conductscience.org/library/papers/41435219 | PubMed |
| 41012605 | Antiviral Strategies Targeting Enteroviruses: Current Advances and Future Directions. | Viruses | 2025 | https://conductscience.org/library/papers/41012605 | PubMed |
| 40879203 | A review of post-exposure strategies for high-consequence viral pathogens in the laboratory. | Clin Microbiol Rev | 2025 | https://conductscience.org/library/papers/40879203 | PubMed |
| 40455159 | Generative Artificial Intelligence for Virology. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40455159 | PubMed |
| 40302715 | Toward Personalized Medicine: The Effect of Treatment of Chronic Enterovirus Diarrhea in an Immunocompromised Patient and the Correlation With In Vitro Models. | Open Forum Infect Dis | 2025 | https://conductscience.org/library/papers/40302715 | PubMed |
| 40164668 | Computational discovery of natural inhibitors targeting enterovirus D68 3C protease using molecular docking pharmacokinetics and dynamics simulations. | Sci Rep | 2025 | https://conductscience.org/library/papers/40164668 | PubMed |
| 39933052 | Structural Chemistry of Helicase Inhibition. | J Med Chem | 2025 | https://conductscience.org/library/papers/39933052 | PubMed |
| 39858967 | In Vivo and In Vitro Studies Assessing the Antiviral Efficacy of Double Combinations Against Coxsackievirus B Infection. | Microorganisms | 2025 | https://conductscience.org/library/papers/39858967 | PubMed |
| 39010093 | Enteroviruses: epidemic potential, challenges and opportunities with vaccines. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/39010093 | PubMed |
| 38787262 | Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication. | Pathogens | 2024 | https://conductscience.org/library/papers/38787262 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DDX3X | 1654 | PubTator's text mining | https://conductscience.org/library/genes/1654 | NCBI Gene |
| DNAH8 | 1769 | PubTator's text mining | https://conductscience.org/library/genes/1769 | NCBI Gene |
| GBF1 | 8729 | PubTator's text mining | https://conductscience.org/library/genes/8729 | NCBI Gene |
| OSBP | 5007 | PubTator's text mining | https://conductscience.org/library/genes/5007 | NCBI Gene |
| OSBP2 | 23762 | PubTator's text mining | https://conductscience.org/library/genes/23762 | NCBI Gene |
| PI4KB | 5298 | PubTator's text mining | https://conductscience.org/library/genes/5298 | NCBI Gene |
| TMC6 | 11322 | PubTator's text mining | https://conductscience.org/library/genes/11322 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37259352
GET https://conductscience.org/api/papers/v1/37259352/references?page=2